4 Analysts Have This to Say About HealthEquity
Portfolio Pulse from Benzinga Insights
HealthEquity (NASDAQ:HQY) has received 4 bullish ratings from analysts in the last quarter, with an average 12-month price target of $80.25, up 5.25% from the previous average price target of $76.25. No bearish or indifferent ratings were observed.
September 21, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HealthEquity has received positive ratings from analysts, which could potentially boost investor confidence and positively impact the stock price in the short term.
Analyst ratings often influence investor sentiment. In this case, HealthEquity has received 4 bullish ratings, which indicates a positive outlook for the company. This could potentially lead to increased investor confidence and a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100